Bibby M. C. Double J. A. Phillips R. M. Loadman P. M. Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid). 55 2 2 1987 159 163 Br J Cancer PMC2002093 3814485 10.1038/bjc.1987.32
Capanna R. Bertoni F. Bacchini P. Bacci G. Guerra A. Campanacci M. Malignant fibrous histiocytoma of bone. The experience at the Rizzoli Institute: report of 90 cases. 54 1 1 7 1984 177 187 Cancer 6326996 10.1002/1097-0142(19840701)54:1<177::aid-cncr2820540133>3.0.co;2-c
Ghilchik M. W. Shaikh N. A. Beranek P. A. Reed M. J. Cyclical sequential hormonochemotherapy in advanced breast cancer. 295 6607 7 11 1987 1172 1172 Br Med J (Clin Res Ed) PMC1248245 3120930 10.1136/bmj.295.6607.1172
Twentyman P. R. Luscombe M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. 56 3 9 1987 279 285 Br J Cancer PMC2002206 3663476 10.1038/bjc.1987.190
Wood C. B. Habib N. A. Apostolov K. Thompson A. Barker W. Hershman M. Blumgart L. H. Reduction in the stearic to oleic acid ratio in human malignant liver neoplasms. 11 4 12 1985 347 348 Eur J Surg Oncol 2998886
Yip D. K. Auersperg N. The dye-exclusion test for cell viability: persistence of differential staining following fixation. 7 5 Mar-Apr 1972 323 329 In Vitro 4113815 10.1007/BF02661722